(2026). Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic Therapy. Portal Hypertension & Cirrhosis.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic Therapy."
Portal Hypertension & Cirrhosis 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Severe Thrombocytopenia Is Associated With Bleeding in Hepatocellular Carcinoma Patients Receiving Antiangiogenic Therapy."
Portal Hypertension & Cirrhosis, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.